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The peripheral pool of mature B cells in adults 
is composed of several subpopulations, each of 
which is generally thought to make a distinct 
contribution to humoral immunity. As an ex­
ample, natural serum IgM functions as a first 
line of defense against pathogens and is pro­
duced primarily by B1a B cells before exposure 
(Baumgarth et al., 1999; Haas et al., 2005). 
Upon bacterial or viral infection, marginal zone 
(MZ) and B1 B cell subsets respond rapidly, 
constituting the immediate acquired antibody 
response (Martin et al., 2001). Finally, FO (fol­
licular)  B  cells  dominate  the  delayed  highly   
specific antibody response comprised by soma­
tically mutated higher affinity class­switched 
antibodies and memory B cells. These latter 
processes  occur  in  germinal  center  reactions 
that occur after productive interactions between 
responding B cells and antigen­specific helper 
T cells (Martin and Kearney, 2002; McHeyzer­
Williams, 2003).
The  nature  of  the  antigen  itself  can  also 
dictate  which  B  cell  subset  is  recruited  into 
an antibody response. Using model antigens in 
rodents, B cell antigens have been classified as   
either T cell independent (TI) or T cell depen­
dent (TD). TI antigens promote B cell prolifer­
ation, differentiation, and antibody production   
in the absence of T cells and are further clas­
sified into two subgroups: type I (TI­1) or 
type 2 (TI­2). TI­1 antigens are mitogens that 
stimulate all B cells to produce antibody in 
a polyclonal manner and irrespective of an­
tigen specificity. Physiological TI­1 antigens 
include Toll­like receptor (TLR) ligands, such 
as LPS which is expressed by gram negative 
bacteria (Coutinho et al., 1974), or certain   
viral coat proteins (Berberian et al., 1993; Blutt   
et al., 2004). TI­2 antigens are instead com­
posed of repetitive epitopes displayed on a 
backbone that simultaneously engage multiple 
antigen  receptors  on  the  surface  of  antigen­ 
specific B cells. TI­2 antigens elicit robust IgM 
and IgG3 antibody production in a TI fashion, 
although the presence of noncognate T cell 
help promotes production of other IgG iso­
types (Mongini et al., 1984). These TI antigens 
include polysaccharides found on encapsulated 
bacteria and highly organized viral capsid pro­
teins such as those found on vesicular stomatitis 
virus and poliovirus (Bachmann et al., 1995; 
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Humoral immunity to viruses and encapsulated bacteria is comprised of T cell–independent 
type 2 (TI-2) antibody responses that are characterized by rapid antibody production by 
marginal zone and B1 B cells. We demonstrate that toll-like receptor (TLR) ligands  
influence the TI-2 antibody response not only by enhancing the overall magnitude but also 
by skewing this response to one that is dominated by IgG isotypes. Importantly, TLR ligands 
facilitate this response by inducing type I interferon (IFN), which in turn elicits rapid and 
significant amounts of antigen-specific IgG2c predominantly from FO (follicular) B cells. 
Furthermore, we show that although the IgG2c antibody response requires B cell– 
autonomous IFN- receptor signaling, it is independent of B cell–intrinsic TLR signaling. 
Thus, innate signals have the capacity to enhance TI-2 antibody responses by promoting 
participation of FO B cells, which then elaborate effective IgG anti-pathogen antibodies.
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result of innate immune receptor signaling contributes to 
regulating the antibody response.
It has been proposed that in addition to their antigen­ 
specific BCR, B cells may also use innate mechanisms for 
pathogen recognition. However, it is still unclear which of 
the innate receptors are used by B cells or what the conse­
quence of these signals is to the B cell antibody response. The 
rapid TI­2 antibody response provides a temporal bridge be­
tween the early innate and late adaptive immune responses. 
Thus, we were interested to investigate how innate signals 
would augment the TI­2 antibody response and influence 
the different B cell populations during this response.
In this paper, we show that TLR agonists significantly 
enhance the TI­2 antibody response through the elaboration 
of type I IFN that promotes production of IgG2c by FO   
B cells. This contribution elicited by FO B cells is shown to   
accelerate the kinetics and enhance the magnitude and qual­
ity of the TI­2 antibody response. Thus, these data not only 
provide a mechanistic example of how innate immunity   
influences  adaptive  immunity  but  also  define  how  humoral   
immunity counters physiological pathogens that present TI­2 
antigens in the presence of ligands for innate immune receptors.
RESULTS
Poly(I:C) enhances the magnitude and kinetics of the TI-2 
antibody response
Poly(I:C) is a synthetic double­stranded RNA (dsRNA) that 
mimics viral nucleic acids and is recognized by several innate 
PRRs, including the TLR3 receptor. MZ B cells are consid­
ered to be largely responsible for the antibody response to 
TI­2 antigens (Martin et al., 2001) and express significantly 
higher levels of the TLR3 transcript than FO B cells (Genestier 
et al., 2007). Thus, we questioned how poly(I:C) might in­
fluence  the  TI­2  antibody  response  by  immunizing  mice 
with the model TI­2 antigen NP­Ficoll in the presence or 
absence of poly(I:C). These results demonstrated that poly(I:C) 
markedly enhanced the antigen­specific IgG3 and IgG2c 
antibody responses at both day 4 and day 7 after immuniza­
tion (Fig. 1 A). In contrast, poly(I:C) did not alter the day­4 
IgM response but instead promoted a significant decrease in 
the NP­specific IgM response of 1.6­fold at 7 d after immu­
nization (Fig. 1 A).
Overall, poly(I:C) led to a twofold increase in total   
antigen­specific Ig 7 d after immunization (Fig. 1 B). The 
composition of the TI­2 antigen­specific antibody response 
was skewed by poly(I:C) from an IgM­dominated (61.3%) to 
an IgG­dominated (81.6%) response (Fig. 1 B). However, 
poly(I:C) did not similarly enhance the magnitudes of all IgG 
subclasses but, rather, had the most striking effect on the   
NP­specific IgG2c response by accelerating the kinetics and 
increasing the magnitude of this isotype (Fig. 1, A and B). 
Relative to other IgG isotypes, IgG2c is the least abundant 
isotype  produced  during  the  NP­Ficoll  response  in  the   
absence of poly(I:C) (Fig. 1 B; Mongini et al., 1981, 1984). 
Enhancement of the IgG2c response by poly(I:C) was dose 
dependent (Fig. S1 A) and, importantly, not a result of   
Bachmann and Zinkernagel, 1997; Fehr et al., 1998). In con­
trast to TI antigens, TD antigens are generally monomeric 
soluble proteins that display single or few epitopes to antigen­
specific B cells and require cognate T cell help for induction 
of highly specific antibody responses generated through ger­
minal center reactions.
Although not absolute, a general division of labor is also 
acknowledged between B cell subsets and the response to   
TI­2 and TD antigens. B1 and MZ B cell subpopulations 
have been considered to be primarily responsible for the   
antibody response to TI­2 antigens (Fagarasan and Honjo, 
2000; Martin et al., 2001; Balázs et al., 2002), whereas FO   
B cells dominate antibody responses to soluble protein TD 
antigens. In accord with generating rapid antibody responses, 
MZ and B1 B cells have lower thresholds for activation com­
pared with FO B cells and are physically poised at sites either 
in tissues or at the blood–lymphoid interface that facilitates 
these early responses (Martin and Kearney, 2002). B1 and 
MZ B cells are described as innate B cells in that they express 
a restricted repertoire of germline­encoded BCRs with poly­
reactive specificities (Bendelac et al., 2001). Responding MZ 
B cells produce antigen­specific antibody at extrafollicular 
splenic sites early during the antibody response that is low af­
finity and predominantly IgM but also includes limited IgG 
subclasses. Although evidence exists that MZ B cells can also 
mount TD responses and initiate germinal center reactions 
(Song and Cerny, 2003; Phan et al., 2005), the ability of FO   
B cells to directly participate in rapid extrafollicular TI­2 anti­
body responses is minor (Ron and Sprent, 1985; Goud et al., 
1988; Liu et al., 1988).
Characterization  of  the  TI­2  antibody  response  has 
predominantly  relied  on  hapten­coupled  carbohydrates   
as model antigens. However, physiological TI­2 antigens 
would rarely be encountered in isolation but, rather, are 
typically  associated  with  pathogen­associated  molecular 
patterns (PAMPs) recognized by pattern recognition re­
ceptors (PRRs; Janeway, 1989; Snapper, 2006). TLRs are 
one family of innate immune PRRs that have been shown 
to enhance the antibody response (Coutinho et al., 1974; 
Seppälä and Mäkelä, 1984; Sen et al., 2005; Heer et al., 
2007; Rubtsov et al., 2008; Eckl­Dorna and Batista, 2009). 
However, whether this regulation is physiologically rele­
vant has been controversial (Pasare and Medzhitov, 2005; 
Gavin et al., 2006).
A major consequence of signaling by many PRRs is the 
rapid elaboration of inflammatory type I IFN cytokines   
(Baccala et al., 2007; McCartney and Colonna, 2009), and 
many viral and bacterial infections lead to IFN­/ produc­
tion (Bogdan, 2000; Mancuso et al., 2009). Type I IFN has been 
previously characterized to modulate antibody production 
both in vitro and in vivo, including promoting class­switch 
recombination and polarizing antibody responses toward 
IgG2a/c production (Finkelman et al., 1991; Le Bon et al., 
2001, 2006; Coro et al., 2006; Heer et al., 2007). How IFN­
/ acts to effect these changes in humoral immunity is not 
well established, nor is whether the type I IFN produced as a JEM VOL. 207, July 5, 2010 
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somatic hypermutation (MacLennan et al., 2003). Given the 
rapid  nature  of  the  IgG2c  antibody  response  induced  by 
poly(I:C) to NP­Ficoll, we tested whether this would like­
wise be a low­affinity extrafollicular response.
The primary antibody response to NP­Ficoll is dominated 
by Ig+ NP­specific antibodies (Tesch et al., 1984), thus   
we used Ig expression as a surrogate for NP­specific ASCs 
(Claassen et al., 1986; Jacob et al., 1991; García de Vinuesa   
et al., 1999; Shih et al., 2002). NP­Ficoll alone elicited Ig+ 
IgM–expressing ASCs localized to extrafollicular foci in the 
bridging channel of the red pulp (Fig. 2 B) as previously re­
ported (Claassen et al., 1986; García de Vinuesa et al., 1999; 
Shih et al., 2002). NP­Ficoll + poly(I:C) induced not only   
extrafollicular Ig+ IgM–expressing ASCs but also Ig+ IgG2c–
expressing ASCs within extrafollicular foci. Additionally, Ig+ 
plasma cells that lacked IgM or IgG2c expression (Fig. 2 B) 
were also observed with poly(I:C) and are likely to be NP­
specific IgG3­producing ASCs, as this isotype comprised a 
significant amount of the response (Fig. 1 B).
The  relative  affinity  of  poly(I:C)­induced  NP­specific 
IgG2c antibodies was also measured and found to be com­
prised of relatively low­affinity antibodies, which is similar to 
that produced in response to NP­Ficoll alone (Fig. 2 C). In 
addition, this relative affinity did not increase with time indi­
cating the absence of affinity maturation (Fig. 2 C). Thus, we 
show that poly(I:C) promotes a rapid IgG2c class­switched 
TI­2 antibody response characterized by both extrafollicular 
antibody secretion and low­affinity antibodies.
Both splenic and lymph node B cells participate in the poly(I:C)-
elicited IgG2c antibody response to NP-Ficoll
Measuring the frequency of splenic NP­specific IgG2c ASCs 
after immunization with poly(I:C) revealed a relative increase 
in the frequency of splenic NP­specific B cells that differ­
entiated into IgG2c ASCs (Fig. 3 A). In accordance with anti­
body levels in serum (Fig. 1 A), poly(I:C) also promoted a   
nonspecific antibody production by polyclonally activated B 
cells (Fig. S1, B and C). Poly(I:C) alone did not induce either 
NP­specific IgG2c or total antigen nonspecific IgG2c. These 
results were confirmed by measuring the total IgG2c levels 
after immunization with NP­Ficoll ± poly(I:C) (Fig. S1 C). 
Although poly(I:C) was found to increase total IgG2c serum 
levels on day 7, this increase was fully accounted for by the 
increase in NP­specific IgG2c at the same time point (Fig. 1 A). 
Together, these results negate a role for polyclonal IgG2c   
antibody production and verify that poly(I:C) enhances the 
TI­2 antibody response by an antigen­specific mechanism.
It is of note that IgG2c (IgG2a in Igha expressing mouse 
strains) is not only the predominant Ig isotype generated   
in antiviral antibody responses (Coutelier et al., 1987) but is   
also considered a highly effective antipathogen Ig isotype   
(Nimmerjahn and Ravetch, 2005, 2008). Thus, we restricted 
our subsequent focus to understanding the mechanism by   
which poly(I:C) altered the production of this IgG2c response.
Poly(I:C) augments the long-lived IgG2c TI-2 antibody response
NP­Ficoll elicits relatively long­lived serum NP­specific   
antibody responses in the absence of adjuvants (García de 
Vinuesa et al., 1999; Obukhanych and Nussenzweig, 2006). We 
examined the adjuvant efficacy of poly(I:C) on this response 
and found that poly(I:C) significantly enhanced NP­specific 
IgG2c antibody levels at all time points evaluated (Fig. 2 A). 
However, although the levels of long­lived antigen­specific 
antibody were considerably increased, this did not result from 
an increased longevity of the antigen­specific IgG2c antibody 
response as the rate of decline of NP­specific IgG2c antibodies 
was similar regardless of poly(I:C) (Fig. 2 A).
Poly(I:C) facilitates an extrafollicular and low-affinity IgG2c 
antibody response to NP-Ficoll
TI­2 antigens typically elicit a rapid extrafollicular antibody 
response with limited isotype class switching and without   
Figure 1.  Poly(I:C) enhances the anti-
body response to a model TI-2 antigen.  
(A) C57BL/6 mice were immunized with 5 µg 
NP-Ficoll alone or 5 µg NP-Ficoll + 100 µg 
poly(I:C) and serum NP-specific IgM, IgG3, and 
IgG2c antibodies were measured in preimmune 
(day 0 [d0]), day 4, and day 7 after immuniza-
tion sera. Symbols represent individual mice, 
and horizontal bars indicate geometric mean. 
Data were combined from two independent 
experiments with five mice per group per  
experiment. *, P ≤ 0.005. (B) Total serum NP-
specific IgG2c, IgG3, IgG2b, IgG1, and IgM were  
measured 7 d after immunization with NP- 
Ficoll ± poly(I:C). Data represent geometric 
means calculated from data combined from 
two independent experiments, with five mice 
per group per experiment. Geometric means 
from NP-specific IgM, IgG3, and IgG2c responses 
were the same as those represented in A.1488 IFN- drives FO B cell TI-2 responses | Swanson et al.
concomitant decline in the frequency of splenic NP­specific 
IgM ASCs. Furthermore, no significant differences were mea­
sured in the frequency of either NP­specific IgG2c or IgM 
ASCs in the bone marrow of mice regardless of poly(I:C)   
immunization (unpublished data).
Given the accelerated kinetics of the IgG2c response in­
duced by poly(I:C), we initially considered that MZ B cells 
destined to produce IgM were subverted to class switch to 
IgG2c during this TI­2 response. However, antigen­specific 
IgG2c ASCs were also present in the lymph nodes of mice 
immunized with NP­Ficoll + poly(I:C) and were virtually 
absent in mice immunized with antigen alone (Fig. 3 B). As 
MZ B cells do not normally recirculate in rodents (Gray et al., 
1982; Kumararatne et al., 1982), the presence of lymph node 
NP­specific IgG2c ASCs indicated that a non­MZ popula­
tion contributed at least partially to the poly(I:C)­induced 
IgG2c response. Although the capacity of lymph node B cells 
to respond to TI­2 antigens has been shown (Ron and Sprent, 
1985; Goud et al., 1988; Liu et al., 1988; Vinuesa et al., 2003), 
this response is limited with respect to other B cell subsets 
(Martin et al., 2001; Balázs et al., 2002). Thus, our data sug­
gest that innate signals augment the TI­2 antibody response 
in part via enhanced production of antigen­specific IgG2c by 
lymph node B cells.
MZ B cells are not required for the IgG2c antibody 
responses to NP-Ficoll + poly(I:C)
B1 and MZ B cells are considered the major contributors   
to the TI­2 antibody response (Fagarasan and Honjo, 2000; 
Martin et al., 2001). However, with regards to NP­Ficoll in 
particular, MZ B cells have been shown to be predominantly 
responsible for the TI­2 antibody response (Otipoby et al., 
1996; Guinamard et al., 2000; Samardzic et al., 2002; Shih   
et al., 2002). Because MZ B cells are restricted to the spleen 
in rodents, we addressed whether MZ B cells contributed to 
the poly(I:C)­induced IgG2c response by splenectomy and 
immunization with NP­Ficoll ± poly(I:C). As previously re­
ported (Amlot et al., 1985), splenectomized mice mounted 
significantly reduced NP­specific IgM responses at days 4 and 
7 after immunization with NP­Ficoll compared with sham­
operated animals and irrespective of poly(I:C) (Fig. 3 C). 
Likewise, at day 7 the antigen­specific IgG2c response to 
NP­Ficoll alone was diminished approximately sevenfold in 
splenectomized mice (Fig. 3 C). However, in the presence of 
poly(I:C) there was only a twofold reduction in the NP­specific 
IgG2c response measured in asplenic mice as compared with 
controls (Fig. 3 C). These data confirm MZ B cells are largely 
responsible for the NP­Ficoll IgM response and further show 
this is true in the presence of poly(I:C). Conversely, the small 
IgM  and  IgG2c  antibody  responses  generated  in  asplenic 
mice highlight a minor role for FO B cells in the NP­Ficoll 
TI­2 response (Ron and Sprent, 1985; Goud et al., 1988; Liu 
Figure 2.  Poly(I:C) promotes a long-lived, extrafollicular, and  
low-affinity IgG2c antibody response to NP-Ficoll. (A) C57BL/6 mice 
were immunized with either NP-Ficoll alone or with poly(I:C) and serum 
NP-specific IgG2c antibodies measured before and at the indicated days 
after immunization. Data are expressed as the geometric mean ± SEM. 
Results shown are from one representative experiment of two indepen-
dent experiments performed. *, P ≤ 0.002. (B) Histological spleen sections 
from C57BL/6 mice 7 d after immunization with NP-Ficoll or NP-Ficoll + 
poly(I:C). Top panels show sections stained for Ig, IgM, and IgG2c. B cell 
follicles within the white pulp were revealed by IgM staining to provide 
orientation for the general lymphoid architecture. Top panels are 10× 
original magnification with enlarged areas within white outlined boxes 
represented in middle and bottom panels. Bottom panels depict only 
green Ig+ ASCs and white arrows identify IgG2c ASCs. Bars, 50 µm. Data 
are representative of two independent experiments. (C) Relative affinity of 
NP-specific IgG2c antibodies was determined as the binding ratio of NP4/
NP16 and was measured by ELISA. Sera samples were analyzed from mice 
at 7, 14, and 31 d after immunization with NP-Ficoll or NP-Ficoll + poly(I:C). 
Results were combined from two independent experiments with four  
to eight mice per immunization group. Data are expressed as the  
arithmetic mean ± SEM. The NP-specific IgG2c mAb S43-10 was used as a 
positive control for a high-affinity binding antibody.
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To provide further support for this notion, we used a 
second model in which the MZ B cell population was selec­
tively depleted by in vivo treatment with anti­integrin (4/L) 
antibodies (Lu and Cyster, 2002) while FO B cells were left 
et al., 1988; Vinuesa et al., 2003). Collectively, our findings 
suggest that in the presence of poly(I:C), a B cell population 
distinct from MZ B cells is the predominant source of NP­
specific IgG2c.
Figure 3.  Poly(I:C) elicits recruitment of 
FO B cells to participate in the enhanced 
IgG2c TI-2 antibody response. (A) Fre-
quency of splenic NP-specific IgM and IgG2c 
ASCs as measured by ELISPOT 7 d after immu-
nization with either NP-Ficoll alone or NP-
Ficoll + poly(I:C). Each symbol represents an 
individual mouse and horizontal bars indicate 
either mean (IgM) or geometric mean (IgG2c). 
Data was combined from four independent 
experiments with three to five mice per group 
per experiment. *, P < 0.0001. (B) ELISPOT of 
NP-specific IgG2c ASCs in lymph nodes from 
C57BL/6 mice at 7 d after immunization with 
either NP-Ficoll alone or NP-Ficoll + poly(I:C). 
Lymph nodes were pooled from three immu-
nized mice. Data was from two representative 
samples shown for each immunization condi-
tion. Data was from one experiment of two 
independent experiments performed. (C) Wild-
type splenectomized or sham-operated mice 
were immunized with NP-Ficoll alone or NP-
Ficoll + poly(I:C) and serum NP-specific IgM 
and IgG2c antibody measured at days 0, 4, 
and 7 after immunization. Data are expressed 
as the geometric mean + SEM. Results were 
combined from two independent experiments 
with four to six mice per group per experi-
ment. *, P < 0.05. (D) C57BL/6 mice were 
treated with 100 µg each of anti-4 + anti-
L antibodies or isotype control antibodies.  
7 d after antibody injection, mice were immu-
nized with either NP-Ficoll alone or NP-Ficoll + 
poly(I:C) and serum NP-specific IgM and 
IgG2c antibody responses measured at the 
indicated times. Data are expressed as the 
geometric mean + SEM. Results are from one 
experiment with four to five mice per group.  
*, P < 0.05. (E) Frequency of NP-specific IgG2c 
splenic ASCs measured from antibody-treated 
wild-type mice. Symbols are the same as 
those described in D and represent the fre-
quency measured from individual animals. 
Horizontal bars indicate geometric mean. 
Results are from one experiment with four 
mice per group. (F) Representative flow cyto-
metric analysis of CD21 and CD23 expression 
in spleen and lymph node of BL6-IghB1-8/B1-8 
(Igha) mice. Total lymph node cells (5 × 107) 
were transferred to C57BL/6 (Ighb) mice and 
immunized 1 d later. The presence and pheno-
type of transferred Igha+ lymph node B cells 
within a splenic FO B cell gate (CD21int CD23high) and MZ B cell gate (CD21high CD23low) in one representative recipient 1 d after transfer is shown. Recipi-
ent mice were immunized with either NP-Ficoll alone or NP-Ficoll + poly(I:C) and NP-specific IgG2a antibodies measured in sera at the indicated time 
points. Antibody concentrations are shown as relative titers and data are expressed as the geometric mean ± SEM. Results shown from one representative 
experiment of two independent experiments performed, with four mice per group. n.d., not detected. *, P ≤ 0.0003.1490 IFN- drives FO B cell TI-2 responses | Swanson et al.
Poly(I:C) promotes FO B cells to participate in the IgG2c 
class-switched TI-2 antibody response
Our findings indicated that FO B cells contributed signifi­
cantly to the poly(I:C)­induced NP­Ficoll response, although 
the capacity of lymph node B cells to contribute to the TI­2 
antibody response has been considered minimal (Ron and 
Sprent, 1985; Goud et al., 1988; Liu et al., 1988). To directly 
examine if FO B cells mounted poly(I:C)­induced IgG2c   
antibody responses to NP­Ficoll in vivo, we adoptively trans­
ferred lymph node cells from IghB1­8/B1­8 (Igha) mice (Sonoda 
et al., 1997) into recipients and immediately assessed their 
ability to respond to NP­Ficoll ± poly(I:C). The B cells 
within the lymph node were phenotypically homogenous   
as CD21int CD23high FO B cells and maintained this pheno­
type after adoptive transfer (Fig. 3 F). The B1­8 IgH chain con­
fers NP­specificity when paired with an Ig light chain (Jack   
et al., 1977; Reth et al., 1978; Bothwell et al., 1981), effec­
tively increasing the NP­specific cells to 5% of the B cell 
population  (unpublished  data).  Before  immunization,  the 
adoptively transferred FO B cells comprised 2.5% of the 
total splenic B cell compartment, and thus 0.1% of the   
B cells in the recipient were IgMa (B1­8) and NP specific 
(unpublished data).
After immunization with NP­Ficoll alone, adoptively 
transferred FO B cells generated a relatively weak and de­
layed NP­specific IgG2a response (Fig. 3 F). As predicted, 
intact (Belperron et al., 2005, 2007). MZ B cells are retained 
within the MZ by integrin adhesion and are released into 
circulation by administration of anti­integrin mAbs (Fig. S2,   
A and B; Lu and Cyster, 2002). Consistent with the splenec­
tomy data, depletion of MZ B cells led to a large reduction in 
the NP­specific IgM response to NP­Ficoll ± poly(I:C) at 4 d 
after immunization as compared with controls (Fig. 3 D).   
Although a similar reduction in NP­specific IgM was not ob­
served at day 7 after immunization, this time point coincided 
with the return of MZ B cells to the spleen after integrin 
treatment and MZ B cell depletion (Fig. S2). In contrast, 
mice depleted of MZ B cells generated equivalent poly(I:C)­
elicited NP­specific IgG2c responses at all time points evalu­
ated  (Fig.  3  D).  Although  these  results  do  not  formally 
eliminate a role for MZ B cells in the poly(I:C)­induced 
IgG2c response, they illustrate that MZ B cells do not make 
a significant contribution to this response.
It remained possible that MZ B cells relocated outside the 
spleen but were still responsive to poly(I:C) and able to gen­
erate NP­specific IgG2c from this extrasplenic site. How­
ever, this was excluded as the frequency of splenic NP­specific 
IgG2c ASCs generated upon immunization with NP­Ficoll 
+ poly(I:C) was the same regardless of MZ B cell depletion 
(Fig. 3 E). These findings strongly suggest that FO B cells are 
the predominant source of the poly(I:C)­induced IgG2c   
antibody response to the TI­2 antigen NP­Ficoll.
Figure 4.  The TI-2 IgG2c response  
induced by poly(I:C) is not mediated by  
B cell–intrinsic TLR3 signaling. (A) NP- 
specific IgG2c responses in wild type, Tlr3/, 
Mda5/, and Tlr3/ Mda5/ mice mea-
sured from sera collected preimmunization 
(day 0) and at 7 d after NP-Ficoll + poly(I:C) 
immunization. Symbols represent individual 
mice, and horizontal bars indicate geometric 
mean. Shown is one representative of two 
independent experiments performed, with 
four to five mice per group. *, P < 0.05.  
(B) NP-specific IgG2c/a antibody responses  
in mixed bone marrow chimeras 7 d after  
immunization with NP-Ficoll + poly(I:C).  
A mixture of bone marrow cells from B6.C20 
(Igha) and Tlr3/ (Ighb; experimental chime-
ras; filled) or B6.C20 and wild-type C57BL/6 
(Ighb; control chimeras; open) was adoptively 
transferred to lethally irradiated B6.C20 hosts. 
8 wk after reconstitution, chimeras were im-
munized and NP-specific antibody measured 
in preimmune and day-7 sera. Reconstitution 
frequencies of IgMa- and IgMb-expressing  
B cells were measured as described in the 
Materials and methods and found to be 
equivalent between both experimental and 
control chimeras. Symbols represent indi-
vidual chimeric mice, and horizontal bars 
indicate geometric mean. Data were combined 
from two independent experiments with five 
to six mice per group. n.d., not detected.JEM VOL. 207, July 5, 2010 
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reduction observed in the double­deficient mice implicates   
both TLR3 and MDA5 in the recognition of poly(I:C) and sub­
sequent induction of a class­switched IgG2c B cell response.
The requirement for direct TLR signaling by B cells dur­
ing antibody responses has been the subject of recent debate 
(Pasare and Medzhitov, 2005; Gavin et al., 2006; Barr et al., 
2007, 2009; Jegerlehner et al., 2007; Meyer­Bahlburg et al., 
2007). Thus, we next questioned whether B cell–autonomous 
TLR3 signaling was required for the poly(I:C)­induced NP­
Ficoll IgG2c response. To address this, we generated mixed 
bone marrow chimeras whereby wild­type (B6.C20­Igha) 
and either Tlr3/ or Tlr3+/+ (Ighb) B cells were juxtaposed 
in direct competition with each other in recipient mice, and 
we measured the capacity of both populations to generate an 
IgG2a/c antibody response to NP­Ficoll + poly(I:C) (Fig. 4 B). 
In these chimeras, TLR3/ (Ighb) B cells mounted equiv­
alent NP­specific IgG2c responses upon immunization with 
NP­Ficoll + poly(I:C) as compared with wild­type (C57BL/ 
6­Ighb) B cells in control chimeras (Fig. 4 B). These results 
demonstrate that direct TLR3 signaling by B cells is not re­
quired for poly(I:C)­induced TI­2 IgG2c responses. Further­
more, these findings suggest that downstream secondary 
innate  cytokine  signals  induced  by  PRR  signaling  may 
suffice in promoting B cell IgG2c antibody responses.
poly(I:C) markedly enhanced both the magnitude and kinet­
ics of the NP­specific IgG2a response produced from FO B 
cells in vivo (Fig. 3 F) and similar to that elicited by poly(I:C) 
in wild­type mice (Fig. 1 A). Similar findings were found 
when fivefold fewer (107) LN cells were transferred (unpub­
lished data). These findings directly demonstrate that FO B 
cells are able to generate IgG2c/a antibody responses to a TI­2 
antigen and, more importantly, show that this response is 
both accelerated and amplified by poly(I:C). Collectively, 
these results reveal that FO B cells provide a rapid and robust 
innate­like IgG2c antibody response to a TI­2 antigen elic­
ited by poly(I:C).
Poly(I:C)-induced NP-specific IgG2c does not require TLR3 
signaling by B cells
As a dsRNA analogue, poly(I:C) is recognized by both TLR3 
and MDA5 PRRs in vivo (Alexopoulou et al., 2001; Gitlin   
et al., 2006; Kato et al., 2006). To assess the in vivo contribu­
tion of these PRRs in the poly(I:C)­induced IgG2c antibody 
response, Tlr3/ and Mda5/ single and compound mutants 
were immunized with NP­Ficoll + poly(I:C). These results re­
vealed modest but significant reductions in NP­specific IgG2c 
in the absence of either TLR3 or MDA5 that were additive in 
Tlr3/ Mda5/ double mutants (Fig. 4 A). The combined   
Figure 5.  Poly(I:C) induction of IgG2c  
requires type I IFN receptor signaling by  
B cells. (A) NP-specific IgM and IgG2c responses 
in wild-type and Ifnar1/ mice measured from 
sera collected at days 0 and 7 after immuniza-
tion with NP-Ficoll + poly(I:C). Symbols represent   
individual mice, and bars represent geometric 
means. Data were combined from two indepen-
dent experiments with three to five mice per 
group per experiment. *, P ≤ 0.005. (B) C57BL/6 
mice were immunized with 5 µg NP-Ficoll alone 
or in the presence of 100 µg Pam3CSK4 (TLR1/2), 
100 µg poly(I:C) (TLR3), 100 µg 3M-012 (TLR7), 
or 8 × 105 U rIFN-11. NP-specific IgG2c re-
sponses were measured from sera collected 
preimmune (day 0) and at 7 d after immuniza-
tion. Symbols represent individual mice, and 
horizontal bars indicate geometric mean. Shown 
is one representative of two independent experi-
ments performed, with four mice per group.  
(C) Mixed bone marrow chimeras were generated 
as described in Fig. 2 B, except that experimental 
chimeras were generated from the transfer of 
Ifnar1/ (Ighb) + B6.C20 (Igha) bone marrow. 
After reconstitution, chimeric mice were immu-
nized with NP-Ficoll + poly(I:C) and NP-specific 
IgMa, IgMb, IgG2a, and IgG2c serum antibody 
responses measured preimmune (day 0) and at 7 
d after immunization. Symbols represent indi-
vidual mice, and horizontal bars indicate geo-
metric mean. Representative data are from one 
experiment shown of two independent experi-
ments performed, with four mice per group. n.d., 
not detected. *, P < 0.05.1492 IFN- drives FO B cell TI-2 responses | Swanson et al.
IFN­inducing  TLR7  agonist  produced  NP­ 
specific IgG2c antibody responses similar to that 
induced by poly(I:C) (Fig. 5 B). Conversely, the 
Pam3CSK4  TLR1/2  agonist  did  not  promote 
NP­specific IgG2c above levels seen with antigen 
alone (Fig. 5 B). These findings indicate that type 
I IFN­inducing adjuvants promote class­switching 
to IgG2c during the TI­2 antibody response. Fur­
thermore, these results are consistent with results 
showing that type I IFN augments particular iso­
types during the B cell antibody response to soluble protein 
antigens and viruses (Finkelman et al., 1991; Le Bon et al., 
2001; Coro et al., 2006; Heer et al., 2007).
We next considered whether we could bypass the re­
quirement for signaling through PRRs altogether by directly 
providing exogenous type I IFN during immunization. Mice 
immunized with NP­Ficoll and a single administration of 
rIFN­ were found to mount significantly higher levels of 
NP­specific IgG2c than NP­Ficoll alone (Fig. 5 B). Although 
the magnitude of the IgG2c response elicited by rIFN­ im­
munization was reduced compared with poly(I:C) immuni­
zation, it was nevertheless notable that a single treatment 
induced a considerable IgG2c antibody response after 1 wk.
Type I IFN receptor expression by B cells is required  
for the IgG2c TI-2 antibody response
To address whether expression of the type I IFN receptor 
was required by B cells for the poly(I:C)­induced IgG2c TI­2 
response antibody response, Ifnar1/ B cells were evaluated 
in mixed bone marrow chimeras in direct competition with 
wild­type B cells. Antibody responses by Ifnar1/ (Ighb) B cells 
or wild­type B6 (Ighb) B cells were measured as NP­specific 
IgMb and IgG2c, whereas competing wild­type (B6.C20­Igha) 
responses in both experimental and control chimeras were   
detected as NP­specific IgMa and IgG2a (Fig. 5 C).
Upon immunization with NP­Ficoll + poly(I:C), wild­
type (B6­Ighb) B cells in control chimeras mounted significant 
Type I IFN mediates poly(I:C)-induced antigen-specific 
IgG2c during the TI-2 antibody response
Both  TLR3  and  MDA5  dsRNA­sensing  receptors  are   
capable of recognizing poly(I:C) to induce a rapid type I IFN 
response (Alexopoulou et al., 2001; Gitlin et al., 2006; Kato 
et al., 2006; Longhi et al., 2009). Given the accelerated IgG2c 
response to poly(I:C), we assessed the contribution of type I 
IFN to this response by immunizing Ifnar1/ mice. These 
results  showed  that  the  NP­specific  IgG2c  response  to   
poly(I:C) immunization was reduced 90% in Ifnar1/ mice 
compared with wild type (Fig. 5 A) and inversely mirrored 
by a modest but significant increase in the NP­specific IgM   
response over wild­type controls (Fig. 5 A). These findings 
demonstrate that type I IFN signaling is necessary for efficient 
induction of the TI­2 IgG2c antibody response promoted by 
poly(I:C).
Type I IFN is an early hallmark of the antiviral innate im­
mune response initiated from the recognition of viral PAMPs. 
Thus, we predicted that the instruction to class switch to 
IgG2c during the TI­2 antibody response would be a general 
property of all PAMPs capable of stimulating endogenous 
type I IFN production. To test this, we immunized mice 
with a representative group of TLR agonists known to stim­
ulate type I IFN (TLR7 agonist, 3M­012; Gorden et al., 
2005) or not (TLR1/2 agonist, Pam3CSK4; Longhi et al., 
2009) and measured the IgG2c antibody response elicited   
to NP­Ficoll. As predicted, mice immunized with a type I   
Figure 6.  IFN- induces BCR-stimulated FO B cells 
to up-regulate CD69 to a greater extent than MZ  
B cells. (A) Histograms represent flow cytometric analysis 
of IFNR1 surface expression on CD21int CD23high FO B 
cells and CD21high CD23low MZ B cells isolated from naive 
wild-type mice. Isotype control antibody staining for both 
FO (shaded light gray) and MZ (dashed line) B cells is  
provided. Data are representative from two independent 
experiments. (B–D) FO and MZ B cells were sorted to ≥94% 
purity from naive C57BL/6 mice and separately incubated 
with the indicated stimuli in vitro for 6 or 10 h. After  
stimulation, surface expression of CD69 (6 h) or CD86  
(10 h) was subsequently assessed in both B cell populations 
by flow cytometry and data depicted as histograms. The  
following stimuli and doses were used: (B) rIFN- at 1, 10, 
or 100 U/ml; (C) rIFN- at 1 U/ml and anti-IgM F(ab)2 at 
10 µg/ml; (D) LPS at 10 µg/ml. Med, medium. Data are  
representative from at least two independent experiments.JEM VOL. 207, July 5, 2010 
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Overall, these data demonstrate that IFN­ selectively 
acts on BCR­stimulated FO, but not MZ, B cells to elevate 
CD69 surface expression. Type I IFN­mediated surface   
expression of CD69 is inversely correlated with S1P1 chemo­
attractant  receptor  responsiveness  (Shiow  et  al.,  2006),   
suggesting  that  selective  CD69  expression  by  antigen­
  experienced FO B cells could alter the trafficking of these 
cells during a response.
DISCUSSION
Study of B cell antibody response to hapten model antigens 
over the last several decades has provided considerable insight 
into how humoral immunity deals with different types of   
antigens. In particular, the reductionist nature of these model 
antigens facilitated our understanding of how different B cell 
subpopulations respond to distinct antigens. However, it is 
now evident that extrapolating from these studies is limited 
with respect to modeling humoral immunity to physiological 
pathogens. Pathogens such as viruses and bacteria not only 
present TI and TD antigens to B cells but also display a vari­
ety of PAMPs capable of alerting the innate immune system. 
This study addresses how these PAMPs influence humoral 
immunity to TI­2 antigens.
The most dramatic changes elicited by poly(I:C) to the 
TI­2 antibody response were measured in the acceleration   
of the kinetics and overall increase in the magnitude of the 
antigen­specific IgG2c response. Heightened production of 
IgG2c is significant, as this isotype is the most efficient IgG 
subclass for anti­pathogen FcR­mediated effector functions 
(Nimmerjahn and Ravetch, 2005) and has long been recog­
nized as the predominant isotype elicited by viral infections 
(Coutelier et al., 1987). Thus, these findings support the no­
tion that PAMPs polarize antibody responses to those iso­
types best suited to deal with particular pathogens (Janeway, 
1989). We further show that during the TI­2 antibody re­
sponse, poly(I:C) promotes a persistence of elevated levels of 
antigen­specific IgG2c serum antibody, which are similar to 
those previously shown for TD antibody responses (Le Bon 
et al., 2001). The durability of this enhanced response has 
implications for vaccine design given the importance of neu­
tralizing antibody concentration in providing efficacious   
antiviral protective immunity (Bachmann and Zinkernagel, 
1997; Bachmann et al., 1997; Pulendran, 2009).
Generally,  pathogen­specific  antibody  responses  divert 
from characterized hapten­specific responses, as they are typ­
ically faster and elicit IgG isotypes earlier than anti­hapten 
responses (Bachmann and Zinkernagel, 1997). We show that 
including a type I IFN­inducing PRR agonist with the NP­
Ficoll TI­2 antigen results in a rapid anti­hapten IgG2c re­
sponse. This class­switched anti­hapten response more closely 
reflects previously characterized antiviral and antimicrobial 
antibody responses with regard to kinetics, isotype specificity, 
and extrafollicular antibody production, illustrating the ap­
plicability of these studies to model pathogens. For instance, 
among the many arms of the influenza antibody response,   
NP­specific IgMb and IgG2c antibody responses (Fig. 5 C). 
As  predicted  from  immunization  of  IFNR1/  mice   
(Fig. 5 A), Ifnar1/ (Ighb) B cells also produced an NP­specific 
IgMb antibody response (Fig. 5 C). In contrast, Ifnar1/ (Ighb) 
B cells did not generate any significant NP­specific IgG2c 
antibody (Fig. 5 C). Moreover, wild­type (B6.C20­Igha)   
B cells in competition with IgMb­expressing B cells in both 
sets of chimeras made comparable NP­specific IgMa and 
IgG2a antibody responses (Fig. 5 C), further eliminating a 
role for non–B cell hematopoietic populations and indicating 
a B cell–autonomous defect. This impaired ability of Ifnar1/ 
B cells to class switch to IgG2c was not a result of abnormal 
B cell development, as Ifnar1/ mice have normal composi­
tions of mature splenic B cell compartments (Le Bon et al., 
2006; Green et al., 2009).
These data show that Ifnar1/ B cells contribute normally 
to TI­2 IgM responses but that in the presence of type I IFN–
inducing PAMPs such as poly(I:C), they are unable to generate 
antigen­specific IgG2c TI­2 antibody response. This establishes 
an in vivo role for type I IFN receptor signaling by FO B cells 
in directly promoting the production of the antiviral IgG2c iso­
type and, thus, enhancing the B cell antibody response.
IFN- acts selectively on BCR-activated FO B cells  
to increase CD69 expression
FO and MZ B cells express similar levels of the type I IFN 
receptor (Fig. 6 A), excluding differential receptor expression 
as an origin for the dominant FO B cell response to type I IFN­
promoting adjuvants. Thus, we predicted that type I IFN 
differentially influenced FO B cells relative to MZ B cells.
Type I IFN can directly activate B cells in vitro (Morikawa 
et al., 1987; Braun et al., 2002; Coro et al., 2006; Kamphuis 
et al., 2006; Shiow et al., 2006) and in vivo (Chang et al., 
2007; Coro et al., 2006; Shiow et al., 2006). Thus, we   
assessed the ability of IFN­ to activate either FO or MZ B 
cells and found that both populations displayed similar sensi­
tivity and kinetics to recombinant IFN as measured by induc­
tion  of  surface  expression  of  CD69  and  CD86  activation 
antigens (Fig. 6 B and not depicted).
We next questioned whether FO and MZ B cells might 
differ in their response to IFN­ stimulation in the context 
of BCR­mediated activation similar to the situation during 
an antibody response. Concomitant treatment of FO B cells 
with anti­IgM and suboptimal levels of IFN­ led to CD69 
expression to levels greater than those detected with anti­
IgM stimulation alone (Fig. 6 C). In contrast, anti­IgM 
treatment of purified MZ B cells failed to increase CD69 
expression to any appreciable level and, importantly, this 
expression was not enhanced by concomitant IFN­ treat­
ment (Fig. 6 C). The inability of anti­IgM to induce CD69 
expression on MZ B cells was not true of all activation 
markers as anti­IgM ± IFN­ increased CD86 expression 
similar to FO B cells (Fig. 6 C). Furthermore, MZ B cells   
exhibited increased sensitivity to LPS activation as mea­
sured by CD86 expression (Fig. 6 D) as previously shown 
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in  TLR3/  MDA5/  double  knockout  chimeric  mice 
(Longhi et al., 2009), which is similar to our findings with the 
B cell antibody response. As RIG­I is also a cytosolic PRR 
capable of recognizing low­molecular­wt poly(I:C) to signal 
type I IFN production (Kato et al., 2008), we envision that 
this dsRNA sensor is likely responsible for the type I IFN   
that promotes a modest increase in NP­specific IgG2c in the 
double mutants. Ultimately, our data demonstrate that non–
TLR­innate signals, such as type I IFN, can substitute for 
TLR sensing of non­self to augment antibody responses. This 
redundancy in the recognition of poly(I:C) by multiple dsRNA­
sensing receptors highlights the importance of IFN­/ as a 
global non­self warning signal for enhancing the efficiency of 
anti­pathogen antibody responses. Indeed, it has been noted   
that all vertebrates examined have immune systems com­
prised by T and B lymphocytes and genes encoding IFN­ 
and IFN­ (Stetson and Medzhitov, 2006), suggesting that 
the type I IFN­mediated innate response is closely associated 
with adaptive immunity.
For humoral immunity, type I IFN elaborated during   
antiviral responses promotes IgG2a/c antibody production   
in vivo (Finkelman et al., 1991; Heer et al., 2007). However, 
the role for B cell–intrinsic signaling by type I IFN to directly 
instruct IgG2c class switching in vivo is unclear. Specifically, 
signaling through the IFN­R expressed by B and T cells has 
been shown to enhance IFN­–mediated IgM and IgG re­
sponses to soluble proteins (Le Bon et al., 2006). In opposi­
tion, direct IFN­R signaling by B cells has been found to be 
unnecessary for the antiviral IgG2c response during acute in­
fluenza infection (Coro et al., 2006). Using a chimeric B cell 
competition model, we demonstrate that B cell–autonomous 
IFN­R signaling does induce IgG2a/c switching in vivo 
during systemic type I IFN responses, such as that elicited by 
poly(I:C). The discordance between our findings and other 
studies likely illustrates the complexity of additional inflam­
matory cytokines, beyond type I IFN, that are elicited during 
viral infections and that also regulate the instruction to switch 
between Ig subclasses (Coro et al., 2006).
A potential mechanism to account for the type I IFN­ 
induced response from FO B cells is suggested by the ability 
of type I IFN to modulate CD69 expression on FO B cells. 
It has been shown that IFN­induced CD69 surface expression 
inhibits lymphocyte egress from lymphoid organs by the   
concomitant loss of sphingosine­1­phosphate responsiveness 
(Shiow et al., 2006). In accord with this, virus­induced IFN­
/ also causes accumulation of circulating FO B cells to re­
gional lymph nodes early during antiviral responses (Chang   
et al., 2007). The enhanced response by FO B cells to up­
regulate CD69 in response to IFN­ and BCR­mediated   
activation would presumably ensure that these normally 
recirculating  B  cells  would  be  retained  within  secondary 
lymphoid organs where they can receive further noncognate 
secondary  signals  necessary  for  TI­2  antibody  responses 
(Chang et al., 2007). In addition, as TI­2 antigens would 
likely be associated with TD antigens within a pathogen, the 
a localized IgG2c extrafollicular B cell antibody response is de­
tectable within a few days in mediastinal lymph nodes after 
intranasal infection (Coro et al., 2006). Similarly, vesicular 
stomatitis virus has been demonstrated to have a highly or­
ganized antigenic capsid capable of eliciting TI antibody   
responses (Bachmann et al., 1995) while simultaneously 
inducing  an  early  isotype­switched  antibody  response   
(Bachmann et al., 1996). These early class­switched responses 
are not exclusive to antiviral responses, as Salmonella typhimurium 
likewise promotes an extrafollicular IgG2c switched plasma 
cell response detectable 4 d after infection (Cunningham et al., 
2007). Thus, the common feature of this rapid and highly   
efficient IgG subclass elicited to both major anti­pathogen 
responses further highlights the physiological and biological 
relevance of our findings.
Mature naive murine B cells constitutively express tran­
scripts for the majority of TLRs (Barr et al., 2007; Genestier 
et al., 2007; Gururajan et al., 2007), and mature B cells can 
respond  to  TLR3  signaling  in  vitro  (Alexopoulou  et  al., 
2001). The requirement for direct TLR signaling by B cells 
during antibody responses has been controversial. In particu­
lar, previous studies have demonstrated a B cell–intrinsic   
requirement for TLR signaling in the generation of B cell 
antibody responses (Pasare and Medzhitov, 2005; Jegerlehner 
et al., 2007). Conversely, studies have also provided evidence 
that disregards TLR signaling for initiating antibody responses 
and supporting an instructive role for TLRs in augmenting 
antibody isotypes (Gavin et al., 2006). Our results demon­
strate a minor role for TLR3 signaling in optimal induction 
of IgG2c by poly(I:C), supporting previous studies showing 
that TLR signaling is largely unnecessary for efficient anti­
body responses (Gavin et al., 2006). However, the ability of 
Tlr3/ B cells to mount normal antibody responses in re­
constituted hosts clearly negates a role for B cell–intrinsic 
TLR3 signaling in IgG2c induction by poly(I:C). Discrepan­
cies observed in the role of B cell–intrinsic TLR signaling 
may be explained by a lack of direct conjugation of the TLR 
agonist with antigen, whereby conjugation would allow for 
the TLR agonist to be directed through BCR­mediated   
internalization to responding B cells for concomitant TLR 
signaling (Eckl­Dorna and Batista, 2009). Our data do not 
exclude  whether  autonomous  B  cell  expression  of  other 
PRRs, such as MDA5, is required for the IgG2c TI­2 anti­
body response. Whether B cell–intrinsic RIG­I–like helicase 
signaling may affect antibody responses remains unclear but 
would be interesting to address with a TLR3/ MDA5/ 
B cell chimeric model similar to that used here.
Our findings indicate that poly(I:C) is recognized pre­
dominantly by TLR3 and MDA5 for subsequent indirect in­
duction of the TI­2 IgG2c antibody response through type I 
IFN. However, we note that in Tlr3/ Mda5/ double 
knockout mice, poly(I:C) remains able to induce NP­specific 
IgG2c  but  is  80%  reduced  compared  with  wild  type   
(Fig. 4 A), suggesting residual type I IFN induction. In ac­
cordance with this, it has recently been reported that poly(I:C) 
induction of CD4 T cell responses is incompletely abolished JEM VOL. 207, July 5, 2010 
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MATERIALS AND METHODS
Mice. C57BL/6 mice (The Jackson Laboratory) were used directly or bred 
and maintained within the Biological Resource Center at National Jewish 
Health (NJH; Denver, CO). C57BL/6­IghB1­8/B1­8;Igha mice (Sonoda et al., 
1997; gift from K. Rajewsky, Harvard University, Boston, MA) and B6.C20 
mice (C57BL/6 mice congenic for Igha; gift from L. Herzenberg, Stanford 
University, Palo Alto, CA) were both bred and maintained within the Bio­
logical Resource Center at NJH. Ifnar1/ mice (Müller et al., 1994) on the 
C57BL/6 genetic background were provided by P. Marrack (NJH, Denver, 
CO). MDA5/ (Gitlin et al., 2006), Tlr3/, and Mda5/, Tlr3/ mice on 
C57BL/6 genetic backgrounds were maintained at Washington University 
(St. Louis, MO). Tlr3/ mice (Alexopoulou et al., 2001) on the C57BL/6 
background were provided by R. Flavell (Yale University, New Haven, 
CT) and also bred and housed within the NJH Biological Resource Center. 
Animals were used between 8 and 12 wk of age, unless otherwise specified. 
All experiments were performed in accordance with NJH and Washington 
University Institutional Animal Care and Use Committees.
Flow cytometric analyses and antibodies. Spleen and lymph node cells 
were harvested and stained according to standard protocols. Fluorescently 
labeled mAbs against the following mouse surface antigens were used for 
staining and either purchased or isolated and conjugated in our laboratory: 
B220  (RA3­6B2;  BD  and  eBioscience),  IgM  (R33­24.12;  hybridoma), 
IgMb (AF6­78; hybridoma), CD21 (7G6; hybridoma), CD19 (1D3; hybrid­
oma and BD), CD1d (1B1; eBioscience), CD69 (H1.2F3; eBioscience), 
CD86 (GL1; eBioscience), CD23 (B3B4; BD), TCR­ (H57­597; BD), 
IgHB1­8 (anti­idiotype; Ac146; hybridoma; Reth et al., 1979), IgMa (DS­1; 
BD), Ig (JC5­1; SouthernBiotech), IgD (11­26c; BD), CD11a (2D7; BD), 
IFNR1  (MAR1­5A3;  BioLegend),  and  Mouse  IgG1,  isotype  control 
(MOPC­21; BD). For detection of NP­specific B cells by flow cytometry, 
cells were stained with 4­Hydroxy­3­nitrophenylacetyl hapten conjugated 
to Phycoerythrin (NP40–PE; Biosearch Technologies) after standard flow 
cytometric staining protocol. The secondary detection reagent for detecting 
biotin­conjugated antibodies by flow cytometry was streptavidin­PE (eBio­
science). Flow cytometric analyses were performed by acquiring data on   
either a FACSCalibur (BD) or a BD LSRII (BD) and with FlowJo v8.8.6 
software (Tree Star, Inc.).
Immunizations. Mice were immunized i.p. with 5 µg NP (4­Hydroxy­3­
nitrophenylacetic) hapten conjugated to NP–Ficoll (Amino­Ethyl­Carboxy­
Methyl­FICOLL)  at  NP32–,  NP41–,  or  NP50–Ficoll  valencies  (Biosearch 
Technologies). Unless otherwise specified, the following doses of adjuvants 
or cytokines were included with NP­Ficoll in immunizations as detailed: 
100 µg poly(I:C) (polyinosine­polycytidylic acid; InvivoGen), 100 µg 
Pam3CSK4  (N­Palmitoyl­S­[2,3­bis(palmitoyloxy)­(2,  RS)­propyl]­[R]­ 
Cys­[S]­Ser­[S]­Lys4; InvivoGen), 100 µg 3M­012 (33080; TLR7 agonist; 
3M Pharmaceuticals; gift from R. Kedl, NJH), or 8 × 105 U recombinant 
mouse IFN­11 (Genbank accession no. AY225954; gift from R. Kedl, 
NJH). Antigens, adjuvants, and cytokines were either purchased as endo­
toxin free (≤0.125 EU/mg) or tested by an endpoint chromogenic Limulus 
Amebocyte Lysate (LAL) assay (Cambrex) and found to be at levels ≤0.1 EU 
per mouse for immunization.
NP-specific ELISAs. To measure NP­specific serum antibody responses, 
96­well flat­bottom MaxiSorp MicroWell plates (Thermo Fisher Scientific) 
were coated overnight with 2 µg/ml (4­Hydroxy­3­iodo­5­nitrophenylacetyl) 
NIP15–BSA (Biosearch Technologies) diluted in PBS at 4°C. Plates were 
washed once (PBS, 0.1% Tween 20; Thermo Fisher Scientific), blocked 
(PBS, 1% BSA, and 0.05% NaN3) for a minimum of 2 h at 37°C, and washed 
once again. For capture of antigen­specific antibodies, sera were initially di­
luted 1:20 and subsequent threefold serial dilutions were made into blocking 
buffer and incubated overnight at 4°C. Plates were washed three times be­
fore incubation with an alkaline phosphatase (AP)–conjugated goat anti–
mouse  isotype­specific  detection  antibody  (SouthernBiotech)  for  1  h  at 
37°C. After three washes, plates were developed by the addition of alkaline 
loss of S1P1 responsiveness would also be expected to direct 
TI­2 antigen­activated B cells to the T–B cell border where 
associated TD antigens could be presented to antigen­specific 
T cells.
Protective humoral immunity to pathogens is contributed 
by distinct B cell subsets with unique activation requirements 
and response patterns. Studies from dissected model patho­
gens, such as S. pneumoniae and influenza, have taught us that 
multifaceted protective humoral immune responses are com­
prised by a collection of antibodies derived from distinct   
B cell subsets (Baumgarth et al., 1999, 2008; Snapper, 2006). 
Features that dictate which B cell subset responds have been 
characterized, including the intrinsic responsiveness of each   
B cell subset and the biochemical properties of the antigens. 
Yet, it is still not understood how innate signals encountered 
during these infections dictate which B cell subset participates 
in each facet of the antibody response. The TI­2 response to 
NP­Ficoll has been characterized by the domination of IgM 
and IgG3 isotypes derived from MZ B cells (Otipoby et al., 
1996; Guinamard et al., 2000; Samardzic et al., 2002; Shih   
et al., 2002). We demonstrate in this paper that in the pres­
ence of type I IFN innate signals, FO B cells are rapidly pro­
moted to participate in a switched TI­2 antibody response 
through B cell–intrinsic IFN­/ signaling that leads to   
antigen­specific IgG2c antibody production. Whether type I 
IFN recruits additional FO B cells to respond to a TI­2 anti­
gen or promotes enhanced clonal expansion of responding 
antigen­specific FO B cells remains to be established.
Rapid low­affinity extrafollicular innate­like antibody   
responses are crucial to providing early acquired immunity 
against pathogens. This study provides the first direct evi­
dence for an innate­like switched FO B cell antibody re­
sponse to a TI­2 antigen. The participation by FO B cells to 
this switched TI­2 response was unexpected given the long­
standing model that FO B cells are a slower responding B cell 
subset  and  predominately  produce  higher  affinity  post­ 
germinal center antibodies during TD responses (Martin and 
Kearney, 2002; McHeyzer­Williams, 2003). Economically, 
one rationale behind the enhanced contribution of FO B 
cells to providing the IFN­/–induced IgG2c response, as 
opposed to the subset which produces the TI­2 IgM re­
sponse, is that this division of labor allows for IgG2c induc­
tion but not at the expense of the crucial initial IgM response. 
Furthermore, this division of labor illustrates the importance 
of both arms of the anti­pathogen humoral response: a rapid 
IgM response to provide antibody capable of neutralizing and 
controlling the infection and a robust and highly efficient   
IgG2c response effective at specialized FcR­mediated clear­
ance (Nimmerjahn and Ravetch, 2005, 2008). These findings 
propose a novel role for FO B cells in responding to innate 
signals in vivo to participate in innate­like antibody responses. 
Future studies will be required to address whether a discreet 
subset of innate FO B cells exist that solely have the capacity 
to respond in this manner or whether this phenomenon is   
a general characteristic of all FO B cells recruited in response 
to particular innate signals.1496 IFN- drives FO B cell TI-2 responses | Swanson et al.
Epson). Developed spots were counted visually from the scanned images 
and the frequency of NP­specific ASCs per total number of cells plated 
was enumerated.
Splenectomy operations. For both vital splenectomy and sham opera­
tions, 6­wk­old C57BL/6 mice were anesthetized by intraperitoneal injection 
of 100 mg/kg ketamine and 10 mg/kg xylazine, followed by administration 
of a subcutaneous injection of 0.5 mg/kg buprenorphine for pain. Once   
sedated, a 1–1.5­cm incision was made on the upper left abdomen through 
both the peritoneal wall and skin. For splenectomized animals, the spleen 
was exteriorized and the splenic artery and efferent venule were each ligated. 
For sham­operated mice, the spleen was gently replaced back into the abdo­
men. For all animals, the abdominal wall was closed by placing one to two 
sutures through the peritoneal membrane, and subsequently two wound 
clips were placed to adjoin the exterior skin of the incision. Postoperative 
care included administration of 1 ml of subcutaneous saline, rest near an in­
direct heat source, and monitoring until full motility was regained. Pain 
management was achieved by subcutaneous injections of 0.5 mg/kg bu­
prenorphine every 12 h for 2–3 d after surgery. Mice were allowed to re­
cover for 21–29 d after surgery, at which time the total serum IgM was 
determined to be equivalent between the sham­operated and splenecto­
mized groups. At 23–32 d after operation, mice were immunized and serum 
NP­specific antibody responses measured by ELISA as described.
MZ B cell depletion. For selective MZ B cell depletion in vivo, a protocol 
was used that was similar to a previously published protocol (Belperron et al., 
2005, 2007). In brief, C57BL/6 mice were injected i.p. with 100 µg each of 
unconjugated purified rat IgG2a anti–mouse CD11a (Integrin L, LFA­1; 
clone M17/4; hybridoma) and rat IgG2b anti–mouse CD49d (Integrin 4; 
VLA­4; clone PS/2; hybridoma) mAbs diluted together in sterile PBS. Con­
trol mice were injected with 100 µg each of functional grade purified rat 
IgG2a (clone eBR2a; eBioscience) and rat IgG2b isotype control antibodies 
(clone eB149/10H5; eBioscience) also diluted in PBS. 3 h after injection of 
antibodies, mice were bled and PBLs stained for the mature B cell markers 
CD21 and CD1d to verify MZ B cell release into blood. Greater than 80% 
of MZ B cells are depleted entirely from the spleen up to 10 d after injection 
of anti­integrin antibodies (Fig. S2 A), and by 14 d after treatment >60% of   
normal frequencies of MZ B cells have returned to spleen (Fig. S2 A). 
Approximately 10% of the anti­integrin antibodies injected remain within 
circulation 4 d after injection and are essentially completely cleared by 7 d after   
injection (Fig. S2 C). However, surface integrin expression is also down­
modulated by the anti­4/L treatment on remaining T and B lymphocytes 
up to 4 d after injection (Fig. S2D). Thus, for MZ B cell depletion experi­
ments, mice were rested for 7 d after injection of anti­integrin antibodies and 
before immunization (Fig. S2 E) to allow both for clearance of rat anti­
4/L antibodies (Fig. S2 C) and for remaining T and B lymphocytes to   
regain wild­type levels of surface integrin expression (Fig. S2 D). 7 d after 
injection of antibodies, mice were immunized with NP­Ficoll ± poly(I:C) 
as described in Fig. S2 E. Sera were collected either the day before immuni­
zation (preimmune) or at 4 and 7 d after immunization, and serum NP­ 
specific  antibody  responses  were  measured  as  described.  At  7  d  after 
immunization, splenocytes were harvested and the frequency of NP­specific 
ASCs was evaluated by ELISPOT. Depleting anti­integrin antibodies were 
tested by the LAL assay and found to be at levels ≤0.1 EU/ml.
To determine the clearance of serum rat IgG antibodies over time in   
this model, serum was collected from mice injected with either rat IgG anti­ 
integrin and isotype control antibodies and analyzed for the presence of rat 
IgG by ELISA. In brief, plates were coated with 10 µg/ml of unlabeled goat 
anti–rat IgM + IgG (H + L chain specific, absorbed against mouse Ig) anti­
body in PBS overnight at 4°C. After washing (PBS and 0.1% Tween 20), 
plates were blocked for 3 h at 37°C with preimmune C57BL/6 mouse serum 
diluted 1:200 in PBS, 1% BSA, and 0.05% NaN3 and subsequently washed 
twice. Sera and standards were diluted similarly as above and incubated over­
night at 4°C. Plates were washed three times, and bound antibodies were   
detected by incubation with AP­conjugated goat anti–rat IgG (H + L chain 
phosphatase substrate buffer consisting of 1 mg/ml 4­Nitrophenyl phosphate 
disodium salt hexahydrate (Alkaline Phosphatase Substrate; Sigma­Aldrich) 
diluted in 1 M diethanolamine, 8.4 mM MgCl2, and 0.02% NaN3, pH 9.8, 
and absorbance values read at 405 nm (VersaMax ELISA reader; MDS   
Analytical Technologies). The following NP­specific mouse mAbs were 
used as standards to quantify the absolute concentration of NP­specific anti­
body present in the sera of immunized mice: B1­8  (NP­specific IgM; 
Reth et al., 1978), S24/63/63 (NP­specific IgG3; Baumhäckel et al., 1982), 
N1G9 (NP­specific IgG1; Cumano and Rajewsky, 1985), S43­10 (NP­
  specific IgG2c; Reth et al., 1978), and D3­13F1 (NP­specific IgG2b; gift from 
K. Rajewsky). In the cases where a standard was unavailable, the titer at an 
OD50 was determined from the serial dilution curves for each sample.
For both adoptive transfer and mixed bone marrow chimera analyses, 
detection of NP­specific IgG2a or IgG2c serum antibodies by ELISA   
was accomplished with AP­conjugated AffiniPure goat anti–mouse IgG,   
Fc Subclass 2a–specific (Jackson ImmunoResearch Laboratories), or AP­
conjugated AffiniPure goat anti–mouse IgG, Fc Subclass 2c–specific (Jackson 
ImmunoResearch) antibodies, respectively. The detection of NP­specific 
IgMa or IgMb serum antibody responses was accomplished as previously   
described (Rubtsov et al., 2005) with either biotin­conjugated mouse anti­IgMa 
(DS­1; BD) or biotin­conjugated mouse anti­IgMb (AF6­78; BD) antibodies, 
respectively. Plates were subsequently washed three times and bound antibody 
revealed by incubation with AP­conjugated Streptavidin (Southern Biotech).
For affinity maturation measurements, ELISAs were performed as in the 
previous paragraphs with the exception that plates were coated with either 
NP (4­Hydroxy­3­nitrophenylacetyl)4–BSA or NP16–BSA capture antigens 
(Biosearch Technologies) diluted at 2 µg/ml. The ratio of high­affinity anti­
bodies bound to NP4–BSA relative to the total of both high­ and low­ 
affinity antibodies bound to NP16–BSA was calculated as previously described 
(Herzenberg et al., 1980; Cumano and Rajewsky, 1985). In brief, the rela­
tive NP4/NP16 binding ratio for a given sample was calculated as the OD50 
titer of serum antibodies bound to NP4–BSA divided by the OD50 titer of 
antibodies bound to NP16–BSA. The NP­specific mAb S43­10 (Reth et al., 
1978) was used as a positive control for a high­affinity NP­specific IgG2c 
antibody with an affinities of Kd = 2.4 × 108 M for NIP and Kd = 2.8 × 
107 M for NP (Cumano and Rajewsky, 1985).
NP-specific  ELISPOTS. NP­specific ASCs were measured in 96­well 
flat­bottom EIA/RIA high­binding plates (Costar; Corning) coated over­
night at 4°C with 2 µg/ml NIP15­BSA diluted in 0.05 M K2HPO4, pH 8.0. 
Plates were washed three times with PBS before blocking with warm PBS 
and 1% gelatin (Sigma­Aldrich) at 37°C for a minimum of 1 h. Plates were 
washed again three times with PBS before incubation with cells. Cells were 
isolated from spleen, bone marrow, or lymph nodes at the times indicated 
after immunization and seeded in duplicate at a starting density of 0.25–1 × 
107 total viable cells per 100 µl in the first well, and threefold serial dilutions 
were performed down the plate. For those ELISPOTs performed on lymph 
node cells, lymph nodes harvested from three mice within the same treat­
ment group were pooled together to constitute a single sample. Cultured 
cells were incubated at 37°C in 5% CO2 for 6 h in complete IMDM (Invit­
rogen) supplemented with 10% heat­inactivated FBS (Biosource, Invitro­
gen, or Gemini Bio­Products), 2 mM GlutaMAX­I (Invitrogen), 100 U/ml 
Penicillin (Invitrogen), 100 µg/ml Streptomycin (Invitrogen), and 0.05 mM 
2­mercaptoethanol (Sigma­Aldrich). Plates were then washed once with 
H2O and 0.05% Tween 20 for 10 min at room temperature and subse­
quently three times with PBS and 0.1% Tween 20. Secreted antibody was 
detected by incubating plates with an isotype­specific AP­conjugated goat 
anti–mouse Ig (SouthernBiotech) diluted in warm PBS, 1% gelatin, and 
0.05% Tween 20 for 1 h at 37°C. After three washes (PBS, 0.1% Tween 20), 
plates  were  developed  overnight  at  4°C  with  1  mg/ml  5­Bromo­4­ 
chloro­3­indolyl phosphate p­toluidine (Sigma­Aldrich) salt substrate diluted 
in an alkaline buffer composed of 0.1 M 2­amino­2­methyl­1­propanol, 
0.01% NaN3, 0.5 mM MgCl2, and 0.007% Triton X­405, pH 10.25. 
Plates were washed four times with deionized H2O, allowed to dry in the 
dark at room temperature, and scanned (Perfection 2450 Photo Scanner; JEM VOL. 207, July 5, 2010 
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in PBS, 2% BSA, and 0.05% Tween 20 at room temperature. Sections were 
stained with antibody mixtures diluted in PBS for 30–60 min at room tem­
perature in the dark, followed by three 5­min washes with shaking with 
PBS. Incubation and washing steps were repeated in the cases where a sec­
ondary detection reagent was used. Sections were dried, mounted with Bion 
IFA mounting medium (Bion Enterprises, Ltd.), visualized at room tempera­
ture with a microscope (Axiovert 200M; Carl Zeiss, Inc.) using a 3i Marianis 
System, and analyzed with Slidebook 4.0 software (Intelligent Imaging In­
novations). Antibodies and secondary reagents used for immunofluorescence 
histological detection included the following: FITC­conjugated rat anti–
mouse CD169 (MOMA­1; AbD Serotec), Alexa Fluor 546–conjugated rat 
anti–mouse IgM (R33­24.12; our laboratory), Alexa Fluor 647–conjugated 
mouse anti–mouse IgD (1.3–5; our laboratory), biotin­conjugated rat anti–
mouse Lambda (JC5­1; SouthernBiotech), streptavidin–FITC (BD), and 
Cy5­conjugated goat anti–mouse IgG, Fc Subclass 2c specific (Jackson 
ImmunoResearch Laboratories). All Alexa Fluor–conjugated antibodies 
were purified and conjugated in our laboratory using Alexa Fluor Protein 
Labeling kits (Invitrogen).
Statistical  and  data  analyses. Data were graphed and analyzed using 
Prism version 5.0a (GraphPad Software). Statistical significance was assessed 
with a Student’s t test with unequal variance, and the appropriateness of one­
tailed or two­tailed significance was determined on an individual experiment 
basis. P­values ≤0.05 were considered significant. Where appropriate, data 
were expressed as the geometric mean ± SEM, unless otherwise stated.
Online supplemental material. Fig. S1 shows dose response of poly(I:C) 
on the production of NP­specific IgG2c and lack of polyclonal IgG2c pro­
duction. Data presented in Fig. S2 characterizes the kinetics of MZ B cell 
depletion by anti­integrin treatment. Online supplemental material is avail­
able at http://www.jem.org/cgi/content/full/jem.20092695/DC1.
The authors wish to thank Paul Waterman, Ginger Woznicki, and Catherine 
Haluszczak for technical assistance, the NJH flow cytometry facility for cell sorting, 
and Philippa Marrack and Ross Kedl for reagents. Additionally, we thank Klaus 
Rajewsky for generosity with reagents and mice. We also appreciate the advice 
and thoughtful comments from Ross Kedl, John Kappler, and members of the  
laboratory during these studies.
This work was supported by the National Institutes of Health (AI052310 to  
R. Pelanda and AI052157 and AI078468 to R.M. Torres).
The authors have no conflicting financial interests.
Submitted: 18 December 2009
Accepted: 17 May 2010
REFERENCES
Alexopoulou,  L.,  A.C.  Holt,  R.  Medzhitov,  and  R.A.  Flavell.  2001. 
Recognition of double­stranded RNA and activation of NF­kappaB by 
Toll­like receptor 3. Nature. 413:732–738. doi:10.1038/35099560
Amlot, P.L., D. Grennan, and J.H. Humphrey. 1985. Splenic dependence 
of the antibody response to thymus­independent (TI­2) antigens. Eur. J. 
Immunol. 15:508–512. doi:10.1002/eji.1830150516
Baccala, R., K. Hoebe, D.H. Kono, B. Beutler, and A.N. Theofilopoulos. 
2007. TLR­dependent and TLR­independent pathways of type I in­
terferon induction in systemic autoimmunity. Nat. Med. 13:543–551. 
doi:10.1038/nm1590
Bachmann,  M.F.,  and  R.M.  Zinkernagel.  1997.  Neutralizing  antiviral  B 
cell responses. Annu. Rev. Immunol. 15:235–270. doi:10.1146/annurev 
.immunol.15.1.235
Bachmann, M.F., H. Hengartner, and R.M. Zinkernagel. 1995. T helper 
cell­independent neutralizing B cell response against vesicular stomati­
tis virus: role of antigen patterns in B cell induction? Eur. J. Immunol. 
25:3445–3451. doi:10.1002/eji.1830251236
Bachmann,  M.F.,  B.  Odermatt,  H.  Hengartner,  and  R.M.  Zinkernagel. 
1996. Induction of long­lived germinal centers associated with persist­
ing antigen after viral infection. J. Exp. Med. 183:2259–2269. doi:10 
.1084/jem.183.5.2259
specific, absorbed against mouse Ig; SouthernBiotech) diluted in PBS, 1% 
BSA, and 0.05% NaN3 buffer for 1 h at 37°C. After three washes, plates 
were developed and absorbances read according to that described for the 
NP­specific ELISA protocol. Purified unlabeled rat IgG antibody (Southern­
Biotech) was used as a standard to quantify the concentration of total serum 
rat IgG for these ELISAs.
Adoptive cell transfers. Lymph node cells were harvested and purified 
from  BL6­IghB1­8/B1­8;Igha  mice  in  IMDM  supplemented  with  5%  FBS, 
washed twice (PBS), and resuspended in sterile PBS. Approximately 5 × 107 
total lymph node cells were injected intravenously into each sex­matched 
C57BL/6­Ighb recipient mouse. 1 d after cell transfer, recipient mice were 
immunized with NP­Ficoll ± poly(I:C) as described. Serum was collected 
before adoptive cell transfer (preimmune) and at 4 and 7 d after immuniza­
tion, and NP­specific antibody responses were subsequently measured by 
ELISA. For phenotypic confirmation, mice were left unimmunized and ver­
ification of transferred IgMa ­expressing B cells within the splenic FO B cell 
compartment of C57BL/6­Ighb recipient mice 1 d after transfer was vali­
dated by flow cytometry.
Mixed bone marrow chimeras. Bone marrow cells were isolated from 
5–7­wk­old C57BL/6 (Ighb), B6.C20 (Igha), Tlr3/ (Ighb), or Ifnar1/ 
(Ighb) donor mice in IMDM supplemented with 5% FBS under sterile con­
ditions. Donor bone marrow cells were washed once with sterile PBS (Cell­
gro; Mediatech, Inc.), resuspended at 1.33–2.67 × 107 cells/ml in PBS, and 
mixed (Ighb + Igha) to yield a final concentration of 2 × 107 cells/ml for re­
constitution. A total of 4 × 106 bone marrow cells were injected intrave­
nously into each sex­matched lethally irradiated (1,000 rad) 6–8­wk­old 
B6.C20 recipients. Recipient mice were maintained on Septra food for 7–8 wk 
after reconstitution. At 8 wk after reconstitution, PBLs from chimeric mice 
were analyzed by flow cytometric analysis to ensure no significant differ­
ences were observed between the ratio of IgMb:IgMa B cell reconstitution 
frequencies in the experimental chimeras as compared with the control chi­
meras. Chimeric mice were immunized at 9 wk after reconstitution and   
serum NP­specific antibody responses were measured by ELISA as described. 
At 14 d after immunization, the ratio of IgMb:IgMa B cell reconstitution 
frequencies was determined within the chimeric splenic mature B cell com­
partments and found to be identical to those previously measured in the 
circulating B cell population.
In vitro stimulation. B cells were negatively enriched from naive C57BL/6 
mice by depletion of CD43+ cells with magnetic cell sorting on LS columns 
(Miltenyi Biotec) with MACS buffer (PBS, 2 mM EDTA, and 0.5% BSA) 
according to the manufacturer’s protocol. MZ (CD21high CD1dhigh) and FO 
(CD21int CD1dint) B cells were subsequently sorted based on surface expres­
sion of CD21 and CD1d to ≥94% purity using a MoFlo XDP Cell Sorter 
(Beckman Coulter) with Summit Software version 5.1.3.6886. Sorted MZ 
and FO B cells were cultured separately at 2.5–5 × 105 cells/ml in 1 ml of com­
plete IMDM in 24­well flat bottom cell culture plates (CELLSTAR; Greiner 
Bio­One) with the indicated stimuli at 37°C in 5% CO2. Stimuli and their   
concentrations cultured with cells included the following: 1–100 U/ml re­
combinant mouse IFN­11 (PBL InterferonSource), 1–10 µg/ml AffiniPure 
F(ab)2 goat anti­mouse IgM,  chain specific (anti­IgM; Jackson Immuno­
Research  Laboratories),  and  0.1–10  µg/ml  LPS  (Escherichia  coli  O26:B6; 
Sigma­Aldrich). B cell activation was subsequently assessed as CD69 and 
CD86 cell surface marker up­regulation measured by flow cytometry   
after stimulation for 6 or 10 h, respectively. Endotoxin levels of stimuli 
used for in vitro cultures were either measured by the LAL assay or purchased 
as <1 EU/µg.
Immunofluorescence histology. Spleens were harvested from mice 7 d 
after immunization and frozen in OCT compound (EM Sciences) at 80°C. 
Tissues were cut into 5–7­µm sections and allowed to dry at room tempera­
ture. Unfixed sections were rehydrated with PBS for 20 min and blocked   
for 15–30 min with rat anti–mouse FcR blocking antibody (2.4G2) diluted 1498 IFN- drives FO B cell TI-2 responses | Swanson et al.
Cumano,  A.,  and  K.  Rajewsky.  1985.  Structure  of  primary  anti­(4­ 
hydroxy­3­nitrophenyl)acetyl  (NP)  antibodies  in  normal  and  idio­
typically  suppressed  C57BL/6  mice.  Eur.  J.  Immunol.  15:512–520. 
doi:10.1002/eji.1830150517
Cunningham, A.F., F. Gaspal, K. Serre, E. Mohr, I.R. Henderson, A. Scott­
Tucker, S.M. Kenny, M. Khan, K.M. Toellner, P.J. Lane, and I.C. 
MacLennan.  2007.  Salmonella  induces  a  switched  antibody  response 
without germinal centers that impedes the extracellular spread of infec­
tion. J. Immunol. 178:6200–6207.
Eckl­Dorna, J., and F.D. Batista. 2009. BCR­mediated uptake of antigen linked 
to TLR9 ligand stimulates B­cell proliferation and antigen­specific plasma 
cell formation. Blood. 113:3969–3977. doi:10.1182/blood­2008­10­185421
Fagarasan, S., and T. Honjo. 2000. T­Independent immune response: new aspects 
of B cell biology. Science. 290:89–92. doi:10.1126/science.290.5489.89
Fehr,  T.,  H.Y.  Naim,  M.F.  Bachmann,  A.F.  Ochsenbein,  P.  Spielhofer,   
E.  Bucher,  H.  Hengartner,  M.A.  Billeter,  and  R.M.  Zinkernagel. 
1998.  T­cell  independent  IgM  and  enduring  protective  IgG  anti­
bodies  induced  by  chimeric  measles  viruses.  Nat.  Med.  4:945–948. 
doi:10.1038/nm0898­945
Finkelman, F.D., A. Svetic, I. Gresser, C. Snapper, J. Holmes, P.P. Trotta, 
I.M. Katona, and W.C. Gause. 1991. Regulation by interferon alpha of 
immunoglobulin isotype selection and lymphokine production in mice. 
J. Exp. Med. 174:1179–1188. doi:10.1084/jem.174.5.1179
García de Vinuesa, C., P. O’Leary, D.M. Sze, K.M. Toellner, and I.C. 
MacLennan. 1999. T­independent type 2 antigens induce B cell pro­
liferation in multiple splenic sites, but exponential growth is confined 
to  extrafollicular  foci.  Eur.  J.  Immunol.  29:1314–1323.  doi:10.1002/
(SICI)1521­4141(199904)29:04<1314::AID­IMMU1314>3.0.CO;2­4
Gavin, A.L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. 
Nemazee. 2006. Adjuvant­enhanced antibody responses in the absence   
of toll­like receptor signaling. Science. 314:1936–1938. doi:10.1126/ 
science.1135299
Genestier,  L.,  M.  Taillardet,  P.  Mondiere,  H.  Gheit,  C.  Bella,  and   
T. Defrance. 2007. TLR agonists selectively promote terminal plasma 
cell differentiation of B cell subsets specialized in thymus­independent 
responses. J. Immunol. 178:7779–7786.
Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R.A. Flavell, M.S. 
Diamond, and M. Colonna. 2006. Essential role of mda­5 in type I 
IFN responses to polyriboinosinic:polyribocytidylic acid and encepha­
lomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA. 103:8459–8464. 
doi:10.1073/pnas.0603082103
Gorden, K.B., K.S. Gorski, S.J. Gibson, R.M. Kedl, W.C. Kieper, X. Qiu, 
M.A. Tomai, S.S. Alkan, and J.P. Vasilakos. 2005. Synthetic TLR ag­
onists reveal functional differences between human TLR7 and TLR8.   
J. Immunol. 174:1259–1268.
Goud, S.N., N. Muthusamy, and B. Subbarao. 1988. Differential responses 
of B cells from the spleen and lymph node to TNP­Ficoll. J. Immunol. 
140:2925–2930.
Gray, D., I.C. MacLennan, H. Bazin, and M. Khan. 1982. Migrant mu+ 
delta+ and static mu+ delta­ B lymphocyte subsets. Eur. J. Immunol. 
12:564–569. doi:10.1002/eji.1830120707
Green, N.M., A. Laws, K. Kiefer, L. Busconi, Y.M. Kim, M.M. Brinkmann, 
E.H. Trail, K. Yasuda, S.R. Christensen, M.J. Shlomchik, et al. 2009. 
Murine B cell response to TLR7 ligands depends on an IFN­beta feedback 
loop. J. Immunol. 183:1569–1576. doi:10.4049/jimmunol.0803899
Guinamard, R., M. Okigaki, J. Schlessinger, and J.V. Ravetch. 2000. Absence 
of marginal zone B cells in Pyk­2­deficient mice defines their role in the 
humoral response. Nat. Immunol. 1:31–36. doi:10.1038/76882
Gururajan, M., J. Jacob, and B. Pulendran. 2007. Toll­like receptor expres­
sion and responsiveness of distinct murine splenic and mucosal B­cell 
subsets. PLoS One. 2:e863. doi:10.1371/journal.pone.0000863
Haas, K.M., J.C. Poe, D.A. Steeber, and T.F. Tedder. 2005. B­1a and   
B­1b cells exhibit distinct developmental requirements and have unique 
functional roles in innate and adaptive immunity to S. pneumoniae. 
Immunity. 23:7–18. doi:10.1016/j.immuni.2005.04.011
Heer, A.K., A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf, 
and  B.J.  Marsland.  2007.  TLR  signaling  fine­tunes  anti­influenza   
B cell responses without regulating effector T cell responses. J. Immunol. 
178:2182–2191.
Bachmann, M.F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H. Roost, 
M. Aguet, H. Hengartner, and R.M. Zinkernagel. 1997. The role of 
antibody concentration and avidity in antiviral protection. Science. 
276:2024–2027. doi:10.1126/science.276.5321.2024
Balázs, M., F. Martin, T. Zhou, and J. Kearney. 2002. Blood dendritic cells in­
teract with splenic marginal zone B cells to initiate T­independent immune   
responses. Immunity. 17:341–352. doi:10.1016/S1074­7613(02)00389­8
Barr, T.A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR­mediated 
stimulation of APC: distinct cytokine responses of B cells and dendritic 
cells. Eur. J. Immunol. 37:3040–3053. doi:10.1002/eji.200636483
Barr, T.A., S. Brown, P. Mastroeni, and D. Gray. 2009. B cell intrinsic   
MyD88 signals drive IFN­gamma production from T cells and control   
switching to IgG2c. J. Immunol. 183:1005–1012. doi:10.4049/jimmunol 
.0803706
Baumgarth, N., O.C. Herman, G.C. Jager, L. Brown, L.A. Herzenberg, and 
L.A. Herzenberg. 1999. Innate and acquired humoral immunities to in­
fluenza virus are mediated by distinct arms of the immune system. Proc. 
Natl. Acad. Sci. USA. 96:2250–2255. doi:10.1073/pnas.96.5.2250
Baumgarth, N., Y.S. Choi, K. Rothaeusler, Y. Yang, and L.A. Herzenberg. 
2008. B cell lineage contributions to antiviral host responses. Curr. Top. 
Microbiol. Immunol. 319:41–61. doi:10.1007/978­3­540­73900­5_3
Baumhäckel, H., B. Liesegang, A. Radbruch, K. Rajewsky, and F. Sablitzky. 
1982. Switch from NP­specific IgG3 to IgG1 in the mouse hybridoma 
cell line S24/63/63. J. Immunol. 128:1217–1220.
Belperron,  A.A.,  C.M.  Dailey,  and  L.K.  Bockenstedt.  2005.  Infection­ 
induced marginal zone B cell production of Borrelia hermsii­specific anti­
body is impaired in the absence of CD1d. J. Immunol. 174:5681–5686.
Belperron, A.A., C.M. Dailey, C.J. Booth, and L.K. Bockenstedt. 2007.   
Marginal zone B­cell depletion impairs murine host defense against   
Borrelia burgdorferi infection. Infect. Immun. 75:3354–3360. doi:10.1128/ 
IAI.00422­07
Bendelac, A., M. Bonneville, and J.F. Kearney. 2001. Autoreactivity by 
design: innate B and T lymphocytes. Nat. Rev. Immunol. 1:177–186. 
doi:10.1038/35105052
Berberian, L., L. Goodglick, T.J. Kipps, and J. Braun. 1993. Immunoglobulin 
VH3 gene products: natural ligands for HIV gp120. Science. 261:1588–
1591. doi:10.1126/science.7690497
Blutt, S.E., S.E. Crawford, K.L. Warfield, D.E. Lewis, M.K. Estes, and   
M.E. Conner. 2004. The VP7 outer capsid protein of rotavirus in­
duces polyclonal B­cell activation. J. Virol. 78:6974–6981. doi:10.1128/ 
JVI.78.13.6974­6981.2004
Bogdan, C. 2000. The function of type I interferons in antimicrobial   
immunity. Curr. Opin. Immunol. 12:419–424. doi:10.1016/S0952­ 
7915(00)00111­4
Bothwell, A.L., M. Paskind, M. Reth, T. Imanishi­Kari, K. Rajewsky, and 
D. Baltimore. 1981. Heavy chain variable region contribution to the 
NPb family of antibodies: somatic mutation evident in a gamma 2a vari­
able region. Cell. 24:625–637. doi:10.1016/0092­8674(81)90089­1
Braun, D., I. Caramalho, and J. Demengeot. 2002. IFN­alpha/beta en­
hances BCR­dependent B cell responses. Int. Immunol. 14:411–419. 
doi:10.1093/intimm/14.4.411
Chang, W.L., E.S. Coro, F.C. Rau, Y. Xiao, D.J. Erle, and N. Baumgarth. 
2007.  Influenza  virus  infection  causes  global  respiratory  tract  B  cell   
response modulation via innate immune signals. J. Immunol. 178:1457– 
1467.
Claassen, E., N. Kors, C.D. Dijkstra, and N. Van Rooijen. 1986. Marginal 
zone of the spleen and the development and localization of specific   
antibody­forming  cells  against  thymus­dependent  and  thymus­ 
independent type­2 antigens. Immunology. 57:399–403.
Coro, E.S., W.L. Chang, and N. Baumgarth. 2006. Type I IFN receptor 
signals directly stimulate local B cells early following influenza virus in­
fection. J. Immunol. 176:4343–4351.
Coutelier, J.P., J.T. van der Logt, F.W. Heessen, G. Warnier, and J. Van 
Snick. 1987. IgG2a restriction of murine antibodies elicited by viral 
infections. J. Exp. Med. 165:64–69. doi:10.1084/jem.165.1.64
Coutinho, A., E. Gronowicz, W.W. Bullock, and G. Möller. 1974. Mecha­
nism of thymus­independent immunocyte triggering. Mitogenic activa­
tion of B cells results in specific immune responses. J. Exp. Med. 139: 
74–92. doi:10.1084/jem.139.1.74JEM VOL. 207, July 5, 2010 
Article
1499
Herzenberg, L.A., S.J. Black, T. Tokuhisa, and L.A. Herzenberg. 1980. 
Memory B cells at successive stages of differentiation. Affinity matu­
ration and the role of IgD receptors. J. Exp. Med. 151:1071–1087. 
doi:10.1084/jem.151.5.1071
Jack, R.S., T. Imanishi­Kari, and K. Rajewsky. 1977. Idiotypic analysis of 
the response of C57BL/6 mice to the (4­hydroxy­3­nitrophenyl)acetyl 
group. Eur. J. Immunol. 7:559–565. doi:10.1002/eji.1830070813
Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the primary im­
mune response to (4­hydroxy­3­nitrophenyl)acetyl. I. The architecture 
and dynamics of responding cell populations. J. Exp. Med. 173:1165–
1175. doi:10.1084/jem.173.5.1165
Janeway, C.A. Jr. 1989. Approaching the asymptote? Evolution and revolu­
tion in immunology. Cold Spring Harb. Symp. Quant. Biol. 54:1–13.
Jegerlehner,  A.,  P.  Maurer,  J.  Bessa,  H.J.  Hinton,  M.  Kopf,  and  M.F. 
Bachmann. 2007. TLR9 signaling in B cells determines class switch re­
combination to IgG2a. J. Immunol. 178:2415–2420.
Kamphuis,  E.,  T.  Junt,  Z.  Waibler,  R.  Forster,  and  U.  Kalinke.  2006. 
Type I interferons directly regulate lymphocyte recirculation and cause 
transient  blood  lymphopenia.  Blood.  108:3253–3261.  doi:10.1182/ 
blood­2006­06­027599
Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, 
S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, et al. 2006. Differential roles 
of MDA5 and RIG­I helicases in the recognition of RNA viruses. 
Nature. 441:101–105. doi:10.1038/nature04734
Kato,  H.,  O.  Takeuchi,  E.  Mikamo­Satoh,  R.  Hirai,  T.  Kawai,  K. 
Matsushita, A. Hiiragi, T.S. Dermody, T. Fujita, and S. Akira. 2008. 
Length­dependent recognition of double­stranded ribonucleic acids by 
retinoic acid–inducible gene­I and melanoma differentiation–associated 
gene 5. J. Exp. Med. 205:1601–1610. doi:10.1084/jem.20080091
Kumararatne, D.S., I.C. MacLennan, H. Bazin, and D. Gray. 1982. Marginal 
zones: the largest B cell compartment of the rat spleen. Adv. Exp. Med. 
Biol. 149:67–73.
Le Bon, A., G. Schiavoni, G. D’Agostino, I. Gresser, F. Belardelli, and D.F. 
Tough. 2001. Type i interferons potently enhance humoral immunity 
and can promote isotype switching by stimulating dendritic cells in vivo. 
Immunity. 14:461–470. doi:10.1016/S1074­7613(01)00126­1
Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. 
Kalinke, and D.F. Tough. 2006. Cutting edge: enhancement of anti­
body responses through direct stimulation of B and T cells by type I 
IFN. J. Immunol. 176:2074–2078.
Liu, Y.J., S. Oldfield, and I.C. MacLennan. 1988. Thymus­independent 
type 2 responses in lymph nodes. Adv. Exp. Med. Biol. 237:113–117.
Longhi, M.P., C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, 
A.M. Salazar, M. Colonna, and R.M. Steinman. 2009. Dendritic cells 
require a systemic type I interferon response to mature and induce CD4+ 
Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206:1589–1602. 
doi:10.1084/jem.20090247
Lu, T.T., and J.G. Cyster. 2002. Integrin­mediated long­term B cell re­
tention  in  the  splenic  marginal  zone.  Science.  297:409–412.  doi:10 
.1126/science.1071632
MacLennan,  I.C.,  K.M.  Toellner,  A.F.  Cunningham,  K.  Serre,  D.M. 
Sze, E. Zúñiga, M.C. Cook, and C.G. Vinuesa. 2003. Extrafollicular 
antibody  responses.  Immunol.  Rev.  194:8–18.  doi:10.1034/j.1600­
065X.2003.00058.x
Mancuso, G., M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, 
G. Teti, and C. Beninati. 2009. Bacterial recognition by TLR7 in the 
lysosomes of conventional dendritic cells. Nat. Immunol. 10:587–594. 
doi:10.1038/ni.1733
Martin,  F.,  and  J.F.  Kearney.  2002.  Marginal­zone  B  cells.  Nat.  Rev. 
Immunol. 2:323–335. doi:10.1038/nri799
Martin, F., A.M. Oliver, and J.F. Kearney. 2001. Marginal zone and B1 B cells 
unite in the early response against T­independent blood­borne particulate 
antigens. Immunity. 14:617–629. doi:10.1016/S1074­7613(01)00129­7
McCartney, S.A., and M. Colonna. 2009. Viral sensors: diversity in patho­
gen recognition. Immunol. Rev. 227:87–94. doi:10.1111/j.1600­065X 
.2008.00726.x
McHeyzer­Williams, M.G. 2003. B cells as effectors. Curr. Opin. Immunol. 
15:354–361. doi:10.1016/S0952­7915(03)00046­3
Meyer­Bahlburg, A., S. Khim, and D.J. Rawlings. 2007. B cell–intrinsic 
TLR signals amplify but are not required for humoral immunity. J. Exp. 
Med. 204:3095–3101. doi:10.1084/jem.20071250
Mongini, P.K., K.E. Stein, and W.E. Paul. 1981. T cell regulation of IgG 
subclass antibody production in response to T­independent antigens.  
J. Exp. Med. 153:1–12. doi:10.1084/jem.153.1.1
Mongini, P.K., D.L. Longo, and W.E. Paul. 1984. T cell regulation of im­
munoglobulin class expression in the B cell response to TNP­Ficoll: 
characterization of the T cell responsible for preferential enhancement 
of the IgG2a response. J. Immunol. 132:1647–1653.
Morikawa,  K.,  H.  Kubagawa,  T.  Suzuki,  and  M.D.  Cooper.  1987. 
Recombinant interferon­alpha, ­beta, and ­gamma enhance the prolif­
erative response of human B cells. J. Immunol. 139:761–766.
Müller,  U.,  U.  Steinhoff,  L.F.  Reis,  S.  Hemmi,  J.  Pavlovic,  R.M. 
Zinkernagel,  and  M.  Aguet.  1994.  Functional  role  of  type  I  and 
type  II  interferons  in  antiviral  defense.  Science.  264:1918–1921. 
doi:10.1126/science.8009221
Nimmerjahn, F., and J.V. Ravetch. 2005. Divergent immunoglobulin g sub­
class activity through selective Fc receptor binding. Science. 310:1510–
1512. doi:10.1126/science.1118948
Nimmerjahn, F., and J.V. Ravetch. 2008. Fcgamma receptors as regulators   
of immune responses. Nat. Rev. Immunol. 8:34–47. doi:10.1038/nri2206
Obukhanych, T.V., and M.C. Nussenzweig. 2006. T­independent type II 
immune responses generate memory B cells. J. Exp. Med. 203:305–310. 
doi:10.1084/jem.20052036
Oliver, A.M., F. Martin, and J.F. Kearney. 1999. IgMhighCD21high lympho­
cytes enriched in the splenic marginal zone generate effector cells more   
rapidly than the bulk of follicular B cells. J. Immunol. 162:7198–7207.
Otipoby, K.L., K.B. Andersson, K.E. Draves, S.J. Klaus, A.G. Farr, J.D. 
Kerner, R.M. Perlmutter, C.L. Law, and E.A. Clark. 1996. CD22 regu­
lates thymus­independent responses and the lifespan of B cells. Nature. 
384:634–637. doi:10.1038/384634a0
Pasare, C., and R. Medzhitov. 2005. Control of B­cell responses by Toll­
like receptors. Nature. 438:364–368. doi:10.1038/nature04267
Phan, T.G., S. Gardam, A. Basten, and R. Brink. 2005. Altered migration, 
recruitment, and somatic hypermutation in the early response of marginal 
zone B cells to T cell­dependent antigen. J. Immunol. 174:4567–4578.
Pulendran, B. 2009. Learning immunology from the yellow fever vaccine: innate 
immunity to systems vaccinology. Nat. Rev. Immunol. 9:741–747.
Reth,  M.,  G.J.  Hämmerling,  and  K.  Rajewsky.  1978.  Analysis  of  the 
repertoire of anti­NP antibodies in C57BL/6 mice by cell fusion. I. 
Characterization of antibody families in the primary and hyperimmune 
response. Eur. J. Immunol. 8:393–400. doi:10.1002/eji.1830080605
Reth, M., T. Imanishi­Kari, and K. Rajewsky. 1979. Analysis of the repertoire 
of anti­(4­hydroxy­3­nitrophenyl)acetyl (NP) antibodies in C 57 BL/6 mice 
by cell fusion. II. Characterization of idiotopes by monoclonal anti­idiotope 
antibodies. Eur. J. Immunol. 9:1004–1013. doi:10.1002/eji.1830091216
Ron, Y., and J. Sprent. 1985. Prolonged survival in vivo of unprimed B cells 
responsive to a T­independent antigen. J. Exp. Med. 161:1581–1586. 
doi:10.1084/jem.161.6.1581
Rubtsov,  A.,  P.  Strauch,  A.  Digiacomo,  J.  Hu,  R.  Pelanda,  and  R.M. 
Torres. 2005. Lsc regulates marginal­zone B cell migration and adhesion 
and is required for the IgM T­dependent antibody response. Immunity. 
23:527–538. doi:10.1016/j.immuni.2005.09.018
Rubtsov, A.V., C.L. Swanson, S. Troy, P. Strauch, R. Pelanda, and 
R.M. Torres. 2008. TLR agonists promote marginal zone B cell 
activation  and  facilitate  T­dependent  IgM  responses.  J.  Immunol. 
180:3882–3888.
Samardzic,  T.,  D.  Marinkovic,  C.P.  Danzer,  J.  Gerlach,  L.  Nitschke,   
and T. Wirth. 2002. Reduction of marginal zone B cells in CD22­
deficient mice. Eur. J. Immunol. 32:561–567. doi:10.1002/1521­4141 
(200202)32:2<561::AID­IMMU561>3.0.CO;2­H
Sen, G., A.Q. Khan, Q. Chen, and C.M. Snapper. 2005. In vivo humoral im­
mune responses to isolated pneumococcal polysaccharides are dependent 
on the presence of associated TLR ligands. J. Immunol. 175:3084–3091.
Seppälä, I.J., and O. Mäkelä. 1984. Adjuvant effect of bacterial LPS and/or 
alum precipitation in responses to polysaccharide and protein antigens. 
Immunology. 53:827–836.1500 IFN- drives FO B cell TI-2 responses | Swanson et al.
Shih, T.A., M. Roederer, and M.C. Nussenzweig. 2002. Role of antigen 
receptor affinity in T cell­independent antibody responses in vivo. Nat. 
Immunol. 3:399–406. doi:10.1038/ni776
Shiow, L.R., D.B. Rosen, N. Brdicková, Y. Xu, J. An, L.L. Lanier, J.G. 
Cyster, and M. Matloubian. 2006. CD69 acts downstream of inter­
feron­alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid 
organs. Nature. 440:540–544. doi:10.1038/nature04606
Snapper,  C.M.  2006.  Differential  regulation  of  protein­  and  polysac­
charide­specific  Ig  isotype  production  in  vivo  in  response  to  intact   
Streptococcus pneumoniae. Curr. Protein Pept. Sci. 7:295–305. doi:10.2174/ 
138920306778017972
Song, H., and J. Cerny. 2003. Functional heterogeneity of marginal zone B 
cells revealed by their ability to generate both early antibody­forming cells   
and germinal centers with hypermutation and memory in response to a T­ 
dependent antigen. J. Exp. Med. 198:1923–1935. doi:10.1084/jem.20031498
Sonoda,  E.,  Y.  Pewzner­Jung,  S.  Schwers,  S.  Taki,  S.  Jung,  D.  Eilat,   
and K. Rajewsky. 1997. B cell development under the condition   
of allelic inclusion. Immunity. 6:225–233. doi:10.1016/S1074­7613 
(00)80325­8
Stetson, D.B., and R. Medzhitov. 2006. Type I interferons in host defense. 
Immunity. 25:373–381. doi:10.1016/j.immuni.2006.08.007
Tesch,  H.,  F.I.  Smith,  W.J.  Müller­Hermes,  and  K.  Rajewsky.  1984. 
Heterogeneous and monoclonal helper T cells induce similar anti­ 
(4­hydroxy­3­nitrophenyl)acetyl (NP) antibody populations in the pri­
mary adoptive response. I. Isotype distribution. Eur. J. Immunol. 14:188–
194. doi:10.1002/eji.1830140215
Vinuesa, C.G., D.M. Sze, M.C. Cook, K.M. Toellner, G.G. Klaus, J. Ball, 
and I.C. MacLennan. 2003. Recirculating and germinal center B cells 
differentiate  into  cells  responsive  to  polysaccharide  antigens.  Eur.  J. 
Immunol. 33:297–305. doi:10.1002/immu.200310003